CAPPED BONUSZERTIFIKAT - STRYKER CORP. Share Price

Certificat

DE000PC5RT28

Real-time Boerse Frankfurt Warrants 07:50:53 13/05/2024 pm IST
249 EUR -0.26% Intraday chart for CAPPED BONUSZERTIFIKAT - STRYKER CORP.
Current month-0.49%
1 month+0.39%
Date Price Change Volume
13/24/13 249 -0.26% 0
10/24/10 249.7 +0.15% 0
09/24/09 249.3 -0.22% 0
08/24/08 249.9 +0.09% 0
07/24/07 249.6 +0.27% 0

Real-time Boerse Frankfurt Warrants

Last update May 13, 2024 at 07:50 pm IST

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC5RT2
ISINDE000PC5RT28
Date issued 27/02/2024
Strike 280 $
Maturity 20/12/2024 (221 Days)
Parity 1 : 1
Emission price 244
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 251.4
Lowest since issue 242.3
Spread 0.5
Spread %0.20%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
330.6 USD
Average target price
372.4 USD
Spread / Average Target
+12.64%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW